M. ASLANER AK Et Al. , "The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data," Society of Hematologic Oncology 2023 Annual Meeting , vol.23, Houstan, United States Of America, pp.358, 2023
ASLANER AK, M. Et Al. 2023. The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data. Society of Hematologic Oncology 2023 Annual Meeting , (Houstan, United States Of America), 358.
ASLANER AK, M., GEDÜK, A., AÇAR, İ. H., POLAT, M. G., SUNU, C., BOLAMAN, A. Z., ... HACIBEKİROĞLU, T.(2023). The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data . Society of Hematologic Oncology 2023 Annual Meeting (pp.358). Houstan, United States Of America
ASLANER AK, MÜZEYYEN Et Al. "The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data," Society of Hematologic Oncology 2023 Annual Meeting, Houstan, United States Of America, 2023
ASLANER AK, MÜZEYYEN A. Et Al. "The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data." Society of Hematologic Oncology 2023 Annual Meeting , Houstan, United States Of America, pp.358, 2023
ASLANER AK, M. Et Al. (2023) . "The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data." Society of Hematologic Oncology 2023 Annual Meeting , Houstan, United States Of America, p.358.
@conferencepaper{conferencepaper, author={MÜZEYYEN ASLANER AK Et Al. }, title={The Long‑Term Efficacy of Erythropoiesis‑Stimulating Agents in Patients With Low‑Risk or Intermediate‑1‑Risk Myelodysplastic Syndrome: Multicenter Real‑Life Data}, congress name={Society of Hematologic Oncology 2023 Annual Meeting}, city={Houstan}, country={United States Of America}, year={2023}, pages={358} }